GCG and acute coronary syndrome: Even in patients with diabetes and nonobstructive CHD, it has been shown that after a non-ST-elevation myocardial infarction, people previously treated with incretins had beneficial effects on all-cause mortality, cardiac death, and readmission for acute coronary syndrome, compared to people not previously treated with incretins [127].